Article
Evaluating the cost-effectiveness of rapid diagnostic testing for the identification of pathogens and resistance genes in bloodstream infections
2025-06-12
Abstract excerpt
<h4>Objectives</h4> Bloodstream infections (BSI) are a leading cause of mortality worldwide. Rapid detection of the causative pathogen can help optimise therapy, reduce mortality, curb antimicrobial resistance, and lower healthcare costs. This study evaluates the cost-effectiveness of adding molecular rapid diagnostic tests (mRDTs) to microbiology standard-of-care (SoC) methods. mRDTs evaluated include the Cobas ®...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6776c484-5345-50d6-9e26-29202c4da9e7
- DOI
- 10.1101/2025.06.12.25329483
